{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:53:23Z","timestamp":1770526403835,"version":"3.49.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>RASopathies, including Noonan syndrome and related disorders, are multisystem conditions caused by mutations in various genes encoding proteins involved in the RAS\/MAPK signaling pathway resulting in increased signal flow. They are clinically characterized by failure to thrive, facial dysmorphisms, congenital heart defects, lymphatic malformations, skeletal anomalies, and variable cognitive impairment, with variable prevalence in the different conditions and subtypes. Pubertal development, which affects growth and final height, is often delayed in Noonan syndrome patients, though not universally. This study aimed to evaluate the timing and progression of puberty and its impact on growth and final height in patients with RASopathies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Subjects and methods<\/jats:title><jats:p>A retrospective longitudinal study was conducted involving 103 patients with molecularly confirmed RASopathies. A subgroup of 40 patients who had completed pubertal development was analyzed. Anthropometric, hormonal (FSH, LH, estradiol\/testosterone), and radiological data were collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 40 patients who had completed puberty, 75% had a diagnosis of Noonan syndrome. The median age at pubertal onset was 11.8 years in males and 13.2 years in females. Delayed puberty was observed in 27.8% of patients, with a higher incidence in females. Median final height was significantly lower in those with delayed pubertal onset compared to those with normal development (p &amp;lt; 0.01). No significant differences in final height were observed between patients with growth hormone deficiency treated with growth hormone and those who were untreated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Delayed pubertal onset negatively impacts final height in patients with RASopathies, with inadequate pubertal catch-up growth being a common outcome. While most patients initiate puberty spontaneously, careful monitoring of growth and pubertal progression is crucial to optimize therapeutic interventions and improve final height outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1531545","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T05:11:02Z","timestamp":1737090662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of pubertal timing on growth progression and final height in subjects affected by RASopathies"],"prefix":"10.3389","volume":"15","author":[{"given":"Federica","family":"Tamburrino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"Gibertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Schiavariello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Orlandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Lanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Scarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.32012","article-title":"The molecular genetics of RASopathies: An update on novel disease genes and new disorders","volume":"190","author":"Tartaglia","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.09.002","article-title":"Noonan syndrome and clinically related disorders","volume":"25","author":"Tartaglia","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/adc.41.219.454","article-title":"Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I","volume":"41","author":"Tanner","year":"1966","journal-title":"Arch Dis Child"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/adc.41.220.613","article-title":"Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II","volume":"41","author":"Tanner","year":"1966","journal-title":"Arch Dis Child"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/03014467600001231","article-title":"The adolescent growth spurt of boys and girls of the Harpenden growth study","volume":"3","author":"Tanner","year":"1976","journal-title":"Ann Hum Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2094","article-title":"Growth response, near-adult height, and patterns of growth and puberty in patients with Noonan syndrome treated with growth hormone","volume":"94","author":"Romano","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000243776","article-title":"Growth in noonan syndrome","author":"Otten","year":"2009","journal-title":"Horm Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2006.104547","article-title":"The natural history of Noonan syndrome: a long-term follow-up study","volume":"92","author":"Shaw","year":"2007","journal-title":"Arch Dis Child"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1213098","article-title":"Abnormalities of pubertal development and gonadal function in Noonan syndrome","volume":"14","author":"Patti","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-006-9021-1","article-title":"Noonan syndrome and related disorders: alterations in growth and puberty","volume":"7","author":"Noonan","year":"2006","journal-title":"Rev Endocr Metab Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30138","article-title":"Noonan syndrome","author":"Allanson","year":"2007","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0092","article-title":"Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: a longitudinal study","volume":"165","author":"Ankarberg-Lindgren","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0582","article-title":"Noonan syndrome males display Sertoli cell-specific primary testicular insufficiency","volume":"179","author":"Moniez","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344156","article-title":"Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)","volume":"29","author":"Cacciari","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.3109\/03014460.2013.772655","article-title":"A new family of mathematical models describing the human growth curve\u2014Erratum: Direct calculation of peak height velocity, age at take-off and associated quantities","volume-title":"Annals of Human Biology","author":"Sayers","year":"2013"},{"key":"B17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/BF00441408","article-title":"Noonan syndrome: growth and clinical manifestations in 144 cases","volume":"148","author":"Ranke","year":"1988","journal-title":"Eur J Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000522670","article-title":"Delayed puberty phenotype observed in noonan syndrome is more pronounced in girls than boys","volume":"95","author":"Rezende","year":"2022","journal-title":"Horm Res Pediatr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37260","article-title":"Response to long-term growth hormone therapy in patients affected by RASopathies and growth hormone deficiency: Patterns of growth, puberty and final height data","author":"Tamburrino","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.761171","article-title":"Growth in children with noonan syndrome and effects of growth hormone treatment on adult height","volume":"12","author":"Libraro","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","article-title":"Growth and pubertal development in five boys with Noonan\u2019s syndrome","volume":"57","author":"Theintz","year":"1982","journal-title":"Arch Dis Child"},{"key":"B24","article-title":"Endocrine profile in Noonan\u2019s syndrome","volume":"12","author":"Sinisi","year":"1987","journal-title":"Minerva Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.31.6.468","article-title":"Genital tract function in men with Noonan syndrome","volume":"31","author":"Elsawi","year":"1994","journal-title":"J Med Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2008.21.11.1079","article-title":"Impaired Sertoli cell function in males diagnosed with Noonan syndrome","volume":"21","author":"Marcus","year":"2008","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1531545\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T05:11:04Z","timestamp":1737090664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1531545\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":26,"alternative-id":["10.3389\/fendo.2024.1531545"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1531545","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"article-number":"1531545"}}